Myriad cancer patent upheld in Australia
Phillip Minnis / Shutterstock.com (High Court of Australia, pictured)
Australia’s highest court has said that naturally occurring nucleic acid molecules are not patentable, overturning a lower court ruling.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at email@example.com
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Myriad Genetics, Yvonne D’Arcy, patent, BRCA1, High Court of Australia